Sigma-Tau Pharmaceuticals, Inc., a leader in the development and commercialization of medicines for patients with rare diseases, announced that the...
Jazz Pharmaceuticals plc has announced that the company has signed a definitive agreement with Sigma-Tau Pharmaceuticals, Inc. under which a...
Sigma Tau Pharma has announced the submission of an application to the European Medicines Agency (EMA) for use of its...
Baxter International Inc.announced it has signed a definitive agreement to acquire the Oncaspar (pegaspargase) product portfolio from Sigma-Tau Finanziaria S.p.A....
Merck KGaA, has announced that approvals have been secured from all relevant jurisdictions for its planned acquisition of U.S.-based life...
Methamphetamine (METH) is a drug with a high addictive potential that is widely abused across the world.
Baxter International Inc. announced that it has received 510(k) clearance from the FDA for its next-generation SIGMA Spectrum Infusion Pump...
Baxter International highlighted a report from KLAS that named the Sigma Spectrum Infusion System the leader among all large-volume infusion...
Baxter International is committed to enhancing patient safety during medication delivery, and highlighted compliance data showing facilities that implemented Sigma...
Introduction: Extracellular tau is hypothesized to mediate the onset and progression of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and a subset of frontotemporal lobar degenerations.